After winning the “Outstanding Enterprise” of the National Brand Yushan Award in 2022, in 2023, MBI competed for the 20th Yushan Award and won three medals, as judged by the jury:
“Ching-Ting Chen, General Manager” – Outstanding Enterprise Leader Award
“Arti-Best® Type I Intra-articular Injection” – Best Product Award
“MBI” – Most Popular Brand Award
The National Brand Yushan Award selects the most competitive brand enterprise after being strictly reviewed by industry, government and academic experts, and is the most important and most credible award made in Taiwan, representing the premium image of both “quality, taste and brand”. The state supports the industry to move up on the smile curve. MBI has recently been pursuing corporate sustainability with a positive strategy and organizational transformation, hard power of operational performance and technological innovation, while strengthening the ESG program.
As a pioneer in the field of medical materials, MBI is committed to providing high quality, safe and reliable products. With accurate market insight and excellence in research and development, the orthopedic product “Arti-Best ® Type I Intra-articular Injection” has been awarded with the “Best Product” for the first time. We are dedicated to continuous innovation and pursuit of excellent quality, and we have a resolute determination to provide comprehensive medical solutions, making a strong commitment to human health.
This year, MBI also won the Most Popular Brand Award! It represents the consumer’s trust in our brand and the high recognition of product quality, and what makes us proud is that Ching-Ting Chen, the General Manager won the “Outstanding Business Leader Award”, showing her excellent leadership ability and contribution to MBI. These awards represent the recognition to our unremitting pursuit of excellence, and also highlights our leading position in the field of medical materials. It also validates our efforts in brand building and leadership.
Act locally and think globally. We are actively increasing global exhibition investment, accelerating market penetration and deepening clinical research collaborations with major medical centers. Focusing on collagen and hyaluronic acid technology, we have successfully developed more than 20 products, covering five major disciplines such as orthopedics, dentistry, medical cosmetology, surgery and ophthalmology. In the future, we will continue to focus on the development of innovative products related to collagen and hyaluronic acid to meet the growing market demand.
With the acceleration of the international market layout, we realize the rapid growth of demand, so we gradually introduce automation and energy-saving equipment, and expand production capacity to adapt to the needs of large-scale intelligent manufacturing. This will enable us to deliver high quality products more efficiently and provide faster delivery services to meet customer expectations. We will continue to uphold the spirit of ensuring excellent quality and making continuous innovations to become the most reliable medical partner!